Blood glucose may condition factor VII levels in diabetic and normal subjects.

scientific article published in December 1988

Blood glucose may condition factor VII levels in diabetic and normal subjects. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/BF00265372
P698PubMed publication ID3240844

P50authorAntonio CerielloQ30347888
Dario GiuglianoQ59197360
P2093author name stringR Torella
A Quatraro
P Dello Russo
P2860cites workFactors of the hemostatic system in diabetic patients. A survey of controlled studiesQ39768937
Preparation of a human factor VII deficient plasmaQ40999623
“What Is Inherited – What Is Added” Hypothesis for the Pathogenesis of Diabetes MellitusQ41528081
Haemostatic variables associated with diabetes and its complicationsQ66971398
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data GroupQ66972631
Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population--II. Baseline data on the relation to blood pressure, blood glucose, uric acid, and lipid fractionsQ69980178
The fluid phase of coagulation and the accelerated atherosclerosis of diabetes mellitusQ70973565
Hyperglycemia and arterial diseaseQ70973574
Haemostatic function and cardiovascular death: early results of a prospective studyQ72423400
Blood fibrinolytic activity in diabetes mellitus and its bearing on ischaemic heart disease and obesityQ79470428
P433issue12
P304page(s)889-891
P577publication date1988-12-01
P1433published inDiabetologiaQ5270140
P1476titleBlood glucose may condition factor VII levels in diabetic and normal subjects.
P478volume31

Reverse relations

cites work (P2860)
Q44962315Activation of Coagulation in Diabetes Mellitus in Relation to the Presence of Vascular Complications
Q35993115Acute hyperglycaemia: a 'new' risk factor during myocardial infarction
Q40898939Admission Glucose Level Predicts In-hospital Mortality in Patients with Acute Pulmonary Embolism Who Were Treated with Thrombolytic Therapy
Q37453099An overview of glycemic control in the coronary care unit with recommendations for clinical management
Q37997963Antithrombotic therapy in patients with acute coronary syndrome and diabetes mellitus
Q33748127Blood glucose as a marker of venous thromboembolism in critically ill children
Q71993564Coagulation Activation in Type 2 Diabetes Mellitus: the Higher Coronary Risk of Female Diabetic Patients
Q40795448Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects
Q35314944Coagulation pathways and diabetic retinopathy: abnormal modulation in a selected group of insulin dependent diabetic patients
Q33983641Diabetes mellitus and coronary heart disease--from prevention to intervention: Part I.
Q37496314Diabetes, Obesity and Atrial Fibrillation: Epidemiology, Mechanisms and Interventions
Q93185962Effects of glycemic control and hypoglycemia on Thrombus formation assessed using automated microchip flow chamber system: an exploratory observational study
Q36839933Effects of hyperglycemia and hyperinsulinemia on the tissue factor pathway of blood coagulation
Q51364256Effects of mealtime insulin aspart and bedtime neutral protamine Hagedorn insulin on postprandial coagulation and fibrinolysis in patients with type 2 diabetes.
Q43571755Factor VII, tissue factor pathway inhibitor, and monocyte tissue factor in diabetes mellitus: influence of type of diabetes, obesity index, and age.
Q41675668Hemostatic concomitants of syndrome X
Q37759238Hyperglycemia: a prothrombotic factor?
Q36323852Lowering blood glucose during hip surgery does not influence coagulation activation
Q36382360Obesity, diabetes and atrial fibrillation; epidemiology, mechanisms and interventions.
Q26752613Options for Controlling Type 2 Diabetes during Ramadan
Q28087462Pathogenesis of diabetic cerebral vascular disease complication
Q58829366Post-meal coagulation activation in diabetes mellitus: the effect of acarbose
Q36632034Postprandial hyperglycaemia and vascular damage--the benefits of acarbose
Q36645776Postprandial insulin resistance as an early predictor of cardiovascular risk.
Q43572444Red wine protects diabetic patients from meal-induced oxidative stress and thrombosis activation: a pleasant approach to the prevention of cardiovascular disease in diabetes
Q33906474Revascularization strategies in patients with diabetes: evolving concepts
Q45309131The Effects of Diet and Insulin Therapy on Coagulation Factor VII, Blood Viscosity, and Platelet Release Proteins in Diabetic Patients with Secondary Sulphonylurea Failure
Q34292419The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus
Q36904452The pathophysiology of cardiovascular disease in diabetes mellitus and the future of therapy
Q33883730The post-prandial state and cardiovascular disease: relevance to diabetes mellitus
Q37176001Venous thromboembolism has the same risk factors as atherosclerosis: A PRISMA-compliant systemic review and meta-analysis

Search more.